152 related articles for article (PubMed ID: 18855118)
1. Sensory-motor polyneuropathy occurring in variant maple syrup urine disease.
Harty S; King MD; McCoy B; Costigan D; Treacy EP
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S209-11. PubMed ID: 18855118
[TBL] [Abstract][Full Text] [Related]
2. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
[TBL] [Abstract][Full Text] [Related]
3. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
[TBL] [Abstract][Full Text] [Related]
4. Variant maple syrup urine disease (MSUD)--the entire spectrum.
Simon E; Flaschker N; Schadewaldt P; Langenbeck U; Wendel U
J Inherit Metab Dis; 2006 Dec; 29(6):716-24. PubMed ID: 17063375
[TBL] [Abstract][Full Text] [Related]
5. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
[TBL] [Abstract][Full Text] [Related]
6. Acute axonal neuropathy in maple syrup urine disease.
Kleopa KA; Raizen DM; Friedrich CA; Brown MJ; Bird SJ
Muscle Nerve; 2001 Feb; 24(2):284-7. PubMed ID: 11180212
[TBL] [Abstract][Full Text] [Related]
7. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P
Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286
[TBL] [Abstract][Full Text] [Related]
8. Living related versus deceased donor liver transplantation for maple syrup urine disease.
Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
[TBL] [Abstract][Full Text] [Related]
9. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H
Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730
[TBL] [Abstract][Full Text] [Related]
10. Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.
Couce ML; Ramos F; Bueno MA; Díaz J; Meavilla S; Bóveda MD; Fernández-Marmiesse A; García-Cazorla A
Eur J Paediatr Neurol; 2015 Nov; 19(6):652-9. PubMed ID: 26232051
[TBL] [Abstract][Full Text] [Related]
11. Intermittent maple syrup urine disease: two case reports.
Axler O; Holmquist P
Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
[TBL] [Abstract][Full Text] [Related]
12. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
[TBL] [Abstract][Full Text] [Related]
13. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
Thompson GN; Francis DE; Halliday D
J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
[TBL] [Abstract][Full Text] [Related]
14. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
[TBL] [Abstract][Full Text] [Related]
15. Computational structural genomics and clinical evidence suggest BCKDK gain-of-function may cause a potentially asymptomatic maple syrup urine disease phenotype.
Singh E; Chi YI; Kopesky J; Zimmerman M; Urrutia R; Basel D; Schwoerer JS
JIMD Rep; 2024 May; 65(3):144-155. PubMed ID: 38736638
[TBL] [Abstract][Full Text] [Related]
16. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP
J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004
[TBL] [Abstract][Full Text] [Related]
17. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
[TBL] [Abstract][Full Text] [Related]
18. Maple syrup urine disease decompensation misdiagnosed as a psychotic event.
Higashimoto T; Whitehead MT; MacLeod E; Starin D; Regier DS
Mol Genet Metab Rep; 2022 Sep; 32():100886. PubMed ID: 35756860
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease.
Simon E; Fingerhut R; Baumkötter J; Konstantopoulou V; Ratschmann R; Wendel U
J Inherit Metab Dis; 2006 Aug; 29(4):532-7. PubMed ID: 16817013
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmoplegia and bulbar palsy in variant form of maple syrup urine disease.
Chhabria S; Tomasi LG; Wong PW
Ann Neurol; 1979 Jul; 6(1):71-2. PubMed ID: 507761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]